|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 31/335 | |||
| A61K 47/02 | |||
| A61K 47/18 | |||
| A61K 9/08 |
| (11) | Number of the document | 2977042 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15185071.6 |
| Date of filing the European patent application | 2007-02-07 | |
| (97) | Date of publication of the European application | 2016-01-27 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-01 |
| (46) | Date of publication of the claims translation |
| (72) |
Singh, Onkar, N., US
Wall, G., Michael, US
Jani, Rajni, US
Chowhan, Masood A., US
Han, Wesley, Wehsin, US
|
| (73) |
Novartis AG,
4002 Basel,
CH
|
| (54) | OLOPATADINE FORMULATIONS FOR TOPICAL NASAL ADMINISTRATION |
| OLOPATADINE FORMULATIONS FOR TOPICAL NASAL ADMINISTRATION |